<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31364344</article-id><article-id pub-id-type="pmc">6852467</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0333</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Early and Long-Term Outcomes of Surgical Treatment of Ebstein&#x02019;s
Anomaly</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4705-2230</contrib-id><name><surname>da Silva</surname><given-names>Guilherme Viotto Rodrigues</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Miana</surname><given-names>Leonardo Augusto</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Caneo</surname><given-names>Luiz Fernando</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Turquetto</surname><given-names>A&#x000ed;da Luiza Ribeiro</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>PhD</role></contrib><contrib contrib-type="author"><name><surname>Tanamati</surname><given-names>Carla</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Penha</surname><given-names>Juliano G.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Jatene</surname><given-names>Fabio B</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Jatene</surname><given-names>Marcelo B</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD, PhD</role></contrib><aff id="aff1">
<label>1</label>Instituto do Cora&#x000e7;&#x000e3;o do Hospital das
Cl&#x000ed;nicas da Faculdade de Medicina da Universidade de S&#x000e3;o Paulo
(InCor-HCFMUSP), S&#x000e3;o Paulo, SP, Brazil.</aff></contrib-group><author-notes><corresp id="c1">Correspondence Address: <bold>Guilherme Viotto Rodrigues da
Silva</bold>, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-4705-2230">https://orcid.org/0000-0003-4705-2230</ext-link> Av. Dr. En&#x000e9;as de
Carvalho Aguiar, 44 - S&#x000e3;o Paulo, SP, Brazil 2nd floor, Office 5 - Zip
Code: 05403-900. E-mail: <email>gviotto@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Sep-Oct</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2019</year></pub-date><volume>34</volume><issue>5</issue><fpage>511</fpage><lpage>516</lpage><history><date date-type="received"><day>20</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>06</day><month>2</month><year>2019</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>This study aimed to evaluate Ebstein&#x02019;s anomaly surgical correction and its
early and long-term outcomes.</p></sec><sec><title>Methods</title><p>A retrospective analysis of 62 consecutive patients who underwent surgical
repair of Ebstein&#x02019;s anomaly in our institution from January 2000 to July
2016. The following long-term outcomes were evaluated: survival,
reoperations, tricuspid regurgitation, and postoperative right ventricular
dysfunction.</p></sec><sec><title>Results</title><p>Valve repair was performed in 46 (74.2%) patients - 12 of them using the Da
Silva cone reconstruction; tricuspid valve replacement was performed in 11
(17.7%) patients; univentricular palliation in one (1.6%) patient; and the
one and a half ventricle repair in four (6.5%) patients. The patients&#x02019; mean
age at the time of surgery was 20.5&#x000b1;14.9 years, and 46.8% of them
were male. The mean follow-up time was 8.8&#x000b1;6 years. The 30-day
mortality rate was 8.06% and the one and 10-year survival rates were 91.9%
both. Eleven (17.7%) of the 62 patients required late reoperation due to
tricuspid regurgitation, in an average time of 7.1&#x000b1;4.9 years after
the first procedure.</p></sec><sec><title>Conclusion</title><p>In our experience, the long-term results of the surgical treatment of
Ebstein's anomaly demonstrate an acceptable survival rate and a low
incidence of reinterventions.</p></sec></abstract><kwd-group><kwd>Ebstein Anomaly</kwd><kwd>Tricuspid Valve Insufficiency</kwd><kwd>Ventricular Dysfunction</kwd><kwd>Right</kwd><kwd>Cardiac Surgical Procedures</kwd><kwd>Survival Rate</kwd></kwd-group></article-meta></front><body><table-wrap id="t6" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="40%" span="1"/><col width="10%" span="1"/><col width="40%" span="1"/></colgroup><thead><tr><th colspan="4" align="left" style="background-color:#CCCCCC" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">ASD</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Atrial septal
defect</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">PV</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Pulmonary valve</td></tr><tr><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">BDG</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Bidirectional Glenn</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">RA</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Right atrial</td></tr><tr><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">BK</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Bundle of Kent</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">RV</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Right
ventricle/ventricular</td></tr><tr><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Coronary artery bypass
graft</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">SD</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Standard deviation</td></tr><tr><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">CR</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1"><break/>
<break/>
<break/>
<break/> = Cone reconstruction</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">SPSS</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Statistical Package for
the Social Sciences</td></tr><tr><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">EA</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Ebstein&#x02019;s anomaly</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">TR</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Tricuspid regurgitation
<break/></td></tr><tr><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">ICU</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Intensive care unit</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">TV</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Tricuspid valve</td></tr><tr><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">IQR</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Interquartile range</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">TVR</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Tricuspid valve
replacement</td></tr><tr><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">LVEF</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Left ventricular
ejection fraction</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">VRP</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Non-Cone valve
repair</td></tr><tr><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">PAPVC</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Partial anomalous
pulmonary venous connection</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">VSD</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Ventricular septal
defect <break/></td></tr><tr><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">PDA</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">= Patent ductus
arteriosus</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">WPW</td><td align="left" style="background-color:#CCCCCC" rowspan="1" colspan="1">=
Wolff-Parkinson-White</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>In 1866, Wilhelm Ebstein described the anatomical findings related to the heart of a
19-year-old man with cyanosis, palpitations, and dyspnea. The postmortem findings
were tricuspid valve (TV) anomaly with dilation of the right ventricle (RV) and
patent foramen ovale. Ebstein&#x02019;s anomaly (EA) is a primary disorder of TV and
accounts for approximately 1% of congenital heart defects<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>The EA is characterized by various degrees of adherence and displacement of the
septal and posterior leaflet into the RV, resulting in a rotational and apical
displacement of TV, an abnormal atrialized portion of RV, tricuspid regurgitation
(TR), and arrhythmias, producing several anatomical variations<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>.</p><p>Surgical treatment of EA was firstly reported by Hunter and Lillehei in
1958<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. Numerous
techniques of tricuspid repair have been published by several authors in an attempt
to eliminate TR and restore RV geometry. However, high incidence of tricuspid
dysfunction and tricuspid valve replacement (TVR) was observed<sup>[<xref rid="r5" ref-type="bibr">5</xref>-<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>In 2004, Da Silva et al.<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup> proposed
the cone reconstruction (CR) of TV, shifting the paradigm of EA surgical management.
Although this technique uses some principles of the Carpentier concepts, bringing
the TV leaflets to the true tricuspid annulus level and longitudinal plication of
the atrialized RV, it adds the advantage of leaflet to leaflet coaptation and
restores RV geometry and function avoiding a prosthetic ring, thus enabling growth
and flexibility of the tricuspid annulus<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p><p>We evaluated the outcomes of patients who underwent surgical correction of EA in our
single center.</p></sec><sec sec-type="methods"><title>METHODS</title><p>We carried out a retrospective, single-center analysis study of all consecutive
patients who underwent surgical treatment for EA. Inclusion criteria were the
diagnosis of EA + atrioventricular and ventriculoarterial concordance. Exclusion
criteria were patients with complex conotruncal abnormalities and neonatal EA
presentation.</p><p>Indications for operations were congestive heart failure symptoms, increasing
cyanosis, atrial or ventricular arrhythmias not amenable to another therapy,
deteriorating systolic function, or progressive dilatation of RV.</p><p>Operative management of EA could be either a biventricular repair, one and a half
ventricle repair, or univentricular palliation. One and a half repair was performed
when the RV was judged not capable of supporting the pulmonary circulation (cases of
severe EA and/or impaired RV function). Univentricular palliation was reserved for
cases of severe RV hypoplasia. Reconstruction of TV or TVR, selective plication of
the atrialized RV, and correction of any associated anomaly was also performed.
Until 2010, the techniques of TV repair used in our institution were those reported
by Danielson et al.<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup> and
Carpentier et al.<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>, and those
consisted of a monocusp repair at the level of the functional annulus. After 2010,
we started to perform the Da Silva CR reported by Da Silva et al.<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup> in all cases of EA repair,
achieving improvement in TV regurgitation and in RV geometry and function.</p><p>Echocardiography was routinely performed preoperatively, intraoperatively, and during
follow-up. TR was categorized into four groups: none, mild, moderate, and
severe.</p><p>The institutional ethics committee on human research approved this study. Due to the
retrospective nature of the study, the need for individual patient consent was
waived.</p><p>Data on demographic variables, intraoperative procedures, and postoperative outcomes
were collected retrospectively. Data were expressed as absolute and percentage
frequency values. For variables with homogeneous distribution, parametric tests were
performed, and the results were presented in mean and standard deviation. As for the
variables with non-homogeneous distribution, we performed non-parametric tests, and
the results were presented in median and interquartile range (IQR). The normality
test used was the Kolmogorov-Smirnov test. Freedom from reoperation and cumulative
survival rates were analyzed according to Kaplan-Meier test. We considered as
statistically significant differences the results with values of
<italic>P</italic>&#x0003c;0.05. Statistical analysis was conducted using the IBM
Statistical Package for the Social Sciences (SPSS) Statistics<sup>&#x000ae;</sup> 20
for Windows (Chicago, Illinois, United States).</p></sec><sec sec-type="results"><title>RESULTS</title><p>From January 2000 through July 2016, 62 consecutive patients were submitted to
surgical correction of EA in our institution. The patients&#x02019; mean age at time of
surgery was 20.5&#x000b1;14.9 years (7 months-68.8 years), and 46.8% of them were
male. One patient had one previous cardiac procedure (atrial septal defect closure)
to the EA correction.</p><p>Preoperative transthoracic echocardiography demonstrated severe TR in 55 (87.5%)
patients, impaired RV systolic function in 16 (25.8%) patients, and low ejection
fraction of left ventricle in two (3.2%) patients. Forty-one patients had an
associated congenital heart lesion, and arrhythmias were present in 20 (32.3%)
patients. Demographic and preoperative data are shown in <xref rid="t1" ref-type="table">Table 1</xref>.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Patients&#x02019; demographic and preoperative data. </p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">Total, n=62
(%)</th></tr></thead><tbody><tr style="border-bottom-style:solid;border-bottom-width:thin;border-top-style:solid;border-top-width:thin"><td align="left" rowspan="1" colspan="1">Male</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">29
(46.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">At presentation</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Mean age &#x00026; #x00b1; SD (years)</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">20.5&#x000b1;14.9</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Weight (kg)</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">45.1&#x000b1;3.4</td></tr><tr style="border-bottom-style:solid;border-bottom-width:thin;border-top-style:solid;border-top-width:thin"><td align="left" rowspan="1" colspan="1">Prior cardiac surgery</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1
(1.61%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Type of associated anomaly</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;ASD</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">40
(64.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;VSD</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">3 (4.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Severe PV anomaly</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">5 (8.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;PDA</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1
(1.61%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;PAPVC</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1
(1.61%)</td></tr><tr style="border-top-style:solid;border-top-width:thin"><td align="left" rowspan="1" colspan="1">Severity of TR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1 (1.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">6 (9.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Severe</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">55
(88.7%)</td></tr><tr style="border-top-style:solid;border-top-width:thin"><td align="left" rowspan="1" colspan="1">Severity of RV systolic dysfunction</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Mild</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">7
(11.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Moderate</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">5 (8.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Severe</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">4 (6.5%)</td></tr><tr style="border-bottom-style:solid;border-bottom-width:thin;border-top-style:solid;border-top-width:thin"><td align="left" rowspan="1" colspan="1">Low LVEF</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">2 (3.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Arrhythmias</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">20
(32.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;WPW syndrome</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">7
(11.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Supraventricular tachycardia</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">6 (9.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Atrial flutter</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">5 (8.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Chronic atrial fibrillation</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">2 (3.2%)</td></tr><tr style="border-bottom-style:solid;border-bottom-width:thin;border-top-style:solid;border-top-width:thin"><td align="left" rowspan="1" colspan="1">Previous ablation</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">9
(14.5%)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>ASD=atrial septal defect; kg=kilograms; LVEF=left ventricular ejection
fraction; PAPVC=partial anomalous pulmonary venous connection;
PDA=patent ductus arteriosus; PV=pulmonary valve; N=number; RV=right
ventricular; SD=standard deviation; TR=tricuspid regurgitation;
VSD=ventricular septal defect; WPW=Wolff-Parkinson-White </p></fn></table-wrap-foot></table-wrap><p>Non-cone valve repair (VRP) was performed in 34 (54.8%) patients; Da Silva CR in 12
(19.4%) patients; TVR in 11 (17.7%) patients - all the replacements were performed
with biological prosthesis; univentricular palliation in one (1.6%) patient, and one
and half ventricle repair in four (6.5%) patients. The mean cardiopulmonary bypass
time was 160.6&#x000b1;61.1 minutes with a mean aortic cross-clamp time of
110.3&#x000b1;35.4 minutes. The median length of stay in the intensive care unit was
six (IQR 3-15,5) days, and the median hospital length of stay after the procedure
was nine (IQR 7-18) days. Operative data are shown in <xref rid="t2" ref-type="table">Table 2</xref>.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Patients&#x02019; operative data. </p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">Total, n=62
(%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">VRP</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">34
(54.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;+CABG</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">2 (3.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;+RA maze</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1 (1.6%)</td></tr><tr style="border-top-style:solid;border-top-width:thin"><td align="left" rowspan="1" colspan="1">CR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">12
(19.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;+RA maze</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1 (1.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;+VSD repair</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1 (1.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;+PV procedure</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">2 (3.2%)</td></tr><tr style="border-top-style:solid;border-top-width:thin"><td align="left" rowspan="1" colspan="1">TVR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">11
(17.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;+RA maze</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">4 (6.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;+VSD repair</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1 (1.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;+PV procedure</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">3 (4.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;+Surgical division BK</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1 (1.6%)</td></tr><tr style="border-bottom-style:solid;border-bottom-width:thin;border-top-style:solid;border-top-width:thin"><td align="left" rowspan="1" colspan="1">Univentricular palliation</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1 (1.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">One and a half ventricle repair</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">4 (6.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;TVR + BDG</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">2 (3.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;CR + BDG</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1 (1.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;CR + BDG+ VSD + PDA repair</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1 (1.6%)</td></tr><tr style="border-bottom-style:solid;border-bottom-width:thin;border-top-style:solid;border-top-width:thin"><td align="left" rowspan="1" colspan="1">Bypass time, min</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">160.6&#x000b1;61.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Cross-clamp time, min</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">110.3
&#x000b1; 35.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Length of ICU stay, days</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">6 (IQR
3-15.5)</td></tr><tr style="border-bottom-style:solid;border-bottom-width:thin;border-top-style:solid;border-top-width:thin"><td align="left" rowspan="1" colspan="1">Length of hospital stay after procedure, days</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">9 (IQR
7-18)</td></tr><tr><td align="left" rowspan="1" colspan="1">Delayed sternal closure</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">3 (4.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Centrifugal pump</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">2 (3.2%)</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>BDG=bidirectional Glenn; BK=bundle of Kent; CABG=coronary artery bypass
graft; CR=cone reconstruction; ICU=intensive care unit;
IQR=interquartile range;min=minutes;&#x000a0; N=number; PDA=patent ductus
arteriosus; PV=pulmonary valve; RA=right atrial; TVR=tricuspid valve
replacement; VRP=non-cone valve repair; VSD=ventricular septal defect
</p></fn></table-wrap-foot></table-wrap><p>There were five deaths, all in the first 30 postoperative days (one - VRP; two - TVR;
two - one and half ventricle repair). There were no late deaths. The causes of death
were three multi-organ dysfunctions + septic sepsis and two cardiogenic shocks.
Centrifugal pump was required in two patients (one patient who underwent TVR and
survived and one who underwent one and a half ventricle repair and died).</p><p>Early reoperation (during the hospital stay) occurred in two patients (3.2%). One
patient (VRP) for recurrent TR, who underwent valve replacement, and one patient
(TVR) who required centrifugal pump, was weaned off from the device, and underwent a
bidirectional Glenn procedure - this patient is currently listed for heart
transplantation due to biventricular dysfunction. Two patients required pacemaker
implantation because they presented advanced heart block during hospitalization,
both underwent VRP.</p><p>Postoperative infection was observed in four patients (6.5%), in a mean of
4.5&#x000b1;0.5 postoperative days; the most common site of infection was the lung,
followed by wound infection.</p><p>Serial echocardiograms were performed in the follow-up period to evaluate TR and RV
systolic function. There were no significant differences on the echocardiographic
data when assessing the entire cohort. Clinically important TV stenosis was not
observed in the VRP and CR groups. Twenty-six patients who underwent VRP and eight
patients who underwent CR had moderate or severe TV insufficiency
(<italic>P</italic>=0.511). Late qualitative assessment of RV dysfunction showed
no statistical difference from the preoperative baseline. Bioprosthesis dysfunction
(stenosis and/or insufficiency greater than moderate) was observed in six patients
who underwent TVR. Postoperative data are shown in <xref rid="t3" ref-type="table">Table 3</xref>.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Patients&#x02019; postoperative data. </p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">VRP (n)</th><th align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">CR (n)</th><th align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">TVR (n)</th><th align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">TV regurgitation grade</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">0.511<xref ref-type="table-fn" rid="TFN3">a</xref><xref ref-type="table-fn" rid="TFN4">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;None/mild</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">7</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">4</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Moderate</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">5</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">3</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Severe</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">21</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">5</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-bottom-style:solid;border-bottom-width:thin;border-top-style:solid;border-top-width:thin"><td align="left" rowspan="1" colspan="1">Bioprosthesis dysfunction</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">6</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">RV dysfunction grade</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">0.181<xref ref-type="table-fn" rid="TFN3">a</xref><xref ref-type="table-fn" rid="TFN5">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;None/mild</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">22</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">11</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">4</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Moderate</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">6</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">0</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">3</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Severe</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">4</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">3</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-bottom-style:solid;border-bottom-width:thin;border-top-style:solid;border-top-width:thin"><td align="left" rowspan="1" colspan="1">Early reoperation</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">0</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">0.627<xref ref-type="table-fn" rid="TFN3">a</xref><xref ref-type="table-fn" rid="TFN5">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Late reoperation</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">8</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">2</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">2</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">0.170<xref ref-type="table-fn" rid="TFN3">a</xref><xref ref-type="table-fn" rid="TFN5">**</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><label>a</label><p>Chi-square test;</p></fn><fn id="TFN4"><label>*</label><p>between VRP and CR group;</p></fn><fn id="TFN5"><label>**</label><p>between all groups</p></fn><fn id="TFN6"><p>CR=cone reconstruction; n=number; RV=right ventricular; TV=tricuspid
valve; TVR=tricuspid valve replacement; VRP=non-cone valve repair</p></fn></table-wrap-foot></table-wrap><p>Mean follow-up time was 8.8&#x000b1;6 years (range: 1 day - 17.8 years). There were no
late deaths, and the overall survival rate at one, five, and 10 years were all 91.9%
(<xref ref-type="fig" rid="f1">Figure 1</xref>). Eleven (17.7%) of 62 patients
required late reoperation due TR, in an average time of 7.1&#x000b1;4.9 years after
the first procedure. Three patients required a second reoperation - two patients
because of bioprosthesis dysfunction and one patient due to TV regurgitation - in an
average time of 6.3&#x000b1;4.7 years after the first reoperation (<xref rid="t4" ref-type="table">Table 4</xref>). Freedom from late reoperation was 79%
at 15 years.</p><p><fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Late survival (Kaplan-Meier) for entire cohort after surgical treatment
of Ebstein&#x02019;s anomaly (n=62).</p></caption><graphic xlink:href="rbccv-34-05-0511-g01"/></fig></p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Characteristics of the patients who underwent late reoperation due to
tricuspid regurgitation. </p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Patient</th><th align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">FP</th><th align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">Reop.</th><th align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">Years since
FP</th><th align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">Sec.
reop.</th><th align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">Years since
first reop.</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">VRP</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">TVR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">16.3</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">VRP</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">TVR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">9.1</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">VRP</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">TVR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1.1</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">TVR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">10.2</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">VRP</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">TVR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">11.3</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-bottom-style:solid;border-bottom-width:thin;border-top-style:solid;border-top-width:thin"><td align="center" rowspan="1" colspan="1">5</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">VRP</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">TVR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">6.4</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">TVR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">7.6</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">VRP</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">TVR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">12.4</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-bottom-style:solid;border-bottom-width:thin;border-top-style:solid;border-top-width:thin"><td align="center" rowspan="1" colspan="1">7</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">VRP</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">VRP</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">3.4</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">8</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">TVR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">TVR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">7.7</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">9</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">VRP</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">Annuloplasty</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1.3</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">TVR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">1.0</td></tr><tr><td align="center" rowspan="1" colspan="1">10</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">CR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">Plasty</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">7.8</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">11</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">CR</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">Plasty</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">2.1</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-bottom-style:solid;border-bottom-width:thin;border-top-style:solid;border-top-width:thin"><td align="center" rowspan="1" colspan="1">Mean&#x000b1;SD</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">7.1&#x000b1;4.9</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-left-style:solid;border-left-width:thin" rowspan="1" colspan="1">6.3&#x000b1;4.7</td></tr></tbody></table><table-wrap-foot><fn id="TFN7"><p>CR=cone reconstruction; FP=first procedure; Reop.=procedure performed in
the reoperation; SD=standard deviation; Sec. reop.=procedure performed
in the second reoperation; TVR=tricuspid valve replacement; VRP=non-cone
valve repair </p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The ideal repair of TV and RV is the anatomical repair, and the surgical treatment of
EA remains a challenge. The mechanism of TR is related to restrictive leaflet
movements, and the first surgical techniques were focused on TV monocusp repair. In
1988, Carpentier et al.<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>
described a new technique that consisted of longitudinal plication of the RV and
return of the TV to the correct level, reinforced with a prosthetic ring. Danielson
et al.<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup> proposed a transverse
plication of the atrialized RV, posterior tricuspid annuloplasty, and right
reduction atrioplasty. Quaegebeur et al.<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup> modified the technique proposed by Carpentier, without the
use of a prosthetic ring. All these techniques reported a high incidence of TV
dysfunction, and TVR was necessary. Until 2010, the methods of TV repair used in our
institution were those published by Danielson et al. and Carpentier et al. and we
found a high incidence of TR.</p><p>In 2004, Da Silva et al.<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup> reported
a new encouraging surgical technique in which the main feature was CR of the TV.
This technique uses some principles of the Carpentier concepts, bringing the TV
leaflets to the true tricuspid annulus level and longitudinal plication of the
atrialized RV, that mimics the normal TV anatomy. In addition to eliminating TR, CR
restores the RV geometry and function, without a prosthetic ring, thus enabling
growth of the tricuspid annulus<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. Late outcomes were reported by Da Silva et al. with low
mortality and efficient TV performance<sup>[<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref>]</sup>.</p><p>After 2010, our group started to perform the CR reported by Da Silva et
al.<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup> in all cases of TV
repair, and we observed good RV function and low incidence of severe TR in long-term
follow-up. Two patients who underwent CR required late reoperation due TR, and TV
re-repair was successful in all cases. In a recent study of 235 patients reported by
the Mayo Clinic group, CR proved to be safe and effective, with a reduction in TR
and changes in RV remodeling<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>.
Encouraging outcomes were reported by other studies performing CR<sup>[<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r15" ref-type="bibr">15</xref>]</sup>. Beroukhim et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup> also reported improvements in RV volume and TR, besides
improvement in left ventricular systolic function and synchrony in patients who
underwent CR<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>.</p><p>Symptomatic EA in early infancy and newborns may present with cyanosis and severe
congestive heart failure. In our study, we excluded the newborn patients because
they mainly represent the worse spectrum of this disease, and the biventricular
repair is often not applied. Besides, outcomes in newborn EA are poorer when
compared with the overall EA population<sup>[<xref rid="r18" ref-type="bibr">18</xref>-<xref rid="r20" ref-type="bibr">20</xref>]</sup>.</p><p>In our experience, freedom from late reoperation was 79% in 15 years. Twelve (19.4%)
patients required late reoperation in an average time of 5.8 &#x000b1; 5.2 years
after the first procedure and three patients required a second reoperation. A
limitation of this study is the small follow-up time to evaluate the need for
reoperation in all TVR patients due the durability of the bioprosthesis. Similar
results were reported by Luu et al.<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup> in a study of 51 patients with EA, and 18% of them required
tricuspid reoperation during their 21-year follow-up. Other studies reported freedom
from reoperation ranging from 88.7% to 92.9% in 10 and 20-year follow-ups,
respectively<sup>[<xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r23" ref-type="bibr">23</xref>]</sup>.</p><p>Total mortality in the current study was 8.1% for all patients in the first 30
postoperative days, and there were no late deaths. In a cohort of 539 patients,
Brown et al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup> reported total
mortality of 29% in a 20-year follow-up and the 30-day and one-, five-, 10-, 15-,
and 20-year survival rates were 94%, 92%, 88%, 85%, 81%, and 71%, respectively. Our
overall survival rate at one, five, and 10 years was 91.9%, respectively.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In conclusion, surgical management of EA remains a challenge. In this series of
patients, our long-term outcomes demonstrate an acceptable survival rate, mortality
limited to the immediate postsurgical period, and a low incidence of reinterventions
and morbidity.</p><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th colspan="2" align="left" valign="top" rowspan="1">Authors&#x02019; roles &#x00026;
responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">GVRS</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LAM</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published <break/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LFC</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ALRT</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CT</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">JGP</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FBJ</td><td align="left" valign="top" rowspan="1" colspan="1">Final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MBJ</td><td align="left" valign="top" rowspan="1" colspan="1">Final approval of the version to be
published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Instituto do Cora&#x000e7;&#x000e3;o do Hospital das
Cl&#x000ed;nicas da Faculdade de Medicina da Universidade de S&#x000e3;o Paulo
(InCor-HCFMUSP), S&#x000e3;o Paulo, SP, Brazil.</p></fn><fn fn-type="COI-statement"><p><bold>No conflict of interest.</bold></p></fn><fn fn-type="financial-disclosure"><p><bold>No financial support.</bold></p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>O'Leary</surname><given-names>PW</given-names></name><name><surname>Dearani</surname><given-names>JA</given-names></name><name><surname>Anderson</surname><given-names>RH</given-names></name></person-group><chapter-title>Diseases of the tricuspid valve</chapter-title><person-group person-group-type="editor"><name><surname>Anderson</surname><given-names>RH</given-names></name><name><surname>Baker</surname><given-names>EJ</given-names></name><name><surname>Penny</surname><given-names>D</given-names></name><name><surname>Redington</surname><given-names>AN</given-names></name><name><surname>Rigby</surname><given-names>ML</given-names></name></person-group><source>Paediatric Cardiology</source><edition>3rd ed</edition><publisher-name>Elsevier</publisher-name><publisher-loc>Churchill Livingstone</publisher-loc><year>2010</year><fpage>713</fpage><lpage>730</lpage></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>SM</given-names></name></person-group><article-title>Ebstein's anomaly: genetics, clinical manifestations, and
management</article-title><source>Pediatr Neonatol</source><year>2017</year><volume>58</volume><issue>3</issue><fpage>211</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.pedneo.2016.08.004</pub-id><pub-id pub-id-type="pmid">28017577</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stulak</surname><given-names>JM</given-names></name><name><surname>Dearani</surname><given-names>JA</given-names></name><name><surname>Danielson</surname><given-names>GK</given-names></name></person-group><article-title>Surgical management of Ebstein's anomaly</article-title><source>Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu</source><year>2007</year><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1053/j.pcsu.2007.01.007</pub-id><pub-id pub-id-type="pmid">17434001</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>SW</given-names></name><name><surname>Lillehei</surname><given-names>CW</given-names></name></person-group><article-title>Ebstein malformation of the tricuspid valve. Study of a case
together with suggestions of a new form of surgical therapy</article-title><source>Dis Chest</source><year>1958</year><volume>33</volume><issue>3</issue><fpage>297</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1378/chest.33.3.297</pub-id><pub-id pub-id-type="pmid">13512138</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>JP</given-names></name><name><surname>Baumgratz</surname><given-names>JF</given-names></name><name><surname>da Fonseca</surname><given-names>L</given-names></name><name><surname>Franchi</surname><given-names>SM</given-names></name><name><surname>Lopes</surname><given-names>LM</given-names></name><name><surname>Tavares</surname><given-names>GM</given-names></name><etal/></person-group><article-title>The cone reconstruction of the tricuspid valve in Ebstein's
anomaly. The operation: early and midterm results</article-title><source>J Thorac Cardiovasc Surg</source><year>2007</year><volume>133</volume><issue>1</issue><fpage>215</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2006.09.018</pub-id><pub-id pub-id-type="pmid">17198815</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danielson</surname><given-names>GK</given-names></name><name><surname>Driscoll</surname><given-names>DJ</given-names></name><name><surname>Mair</surname><given-names>DD</given-names></name><name><surname>Warnes</surname><given-names>CA</given-names></name><name><surname>Oliver</surname><given-names>WC Jr</given-names></name></person-group><article-title>Operative treatment of Ebstein anomaly</article-title><source>J Thorac Cardiovasc Surg</source><year>1992</year><volume>104</volume><issue>5</issue><fpage>1195</fpage><lpage>1202</lpage><pub-id pub-id-type="pmid">1434695</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpentier</surname><given-names>A</given-names></name><name><surname>Chauvaud</surname><given-names>S</given-names></name><name><surname>Mac&#x000e9;</surname><given-names>L</given-names></name><name><surname>Relland</surname><given-names>J</given-names></name><name><surname>Mihaileanu</surname><given-names>S</given-names></name><name><surname>Marino</surname><given-names>JP</given-names></name><etal/></person-group><article-title>A new reconstructive operation for Ebstein's anomaly of the
tricuspid valve</article-title><source>J Thorac Cardiovasc Surg</source><year>1988</year><volume>96</volume><issue>1</issue><fpage>92</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">3386297</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>JP</given-names></name><name><surname>Baumgratz</surname><given-names>JF</given-names></name><name><surname>Fonseca</surname><given-names>L</given-names></name><name><surname>Afiune</surname><given-names>JY</given-names></name><name><surname>Franchi</surname><given-names>SM</given-names></name><name><surname>Lopes</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Ebstein's anomaly. Results of the conical reconstruction of the
tricuspid valve</article-title><source>Arq Bras Cardiol</source><year>2004</year><volume>82</volume><issue>3</issue><fpage>217</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1590/S0066-782X2004000300002</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quaegebeur</surname><given-names>JM</given-names></name><name><surname>Sreenam</surname><given-names>N</given-names></name><name><surname>Fraser</surname><given-names>AG</given-names></name><name><surname>Bogers</surname><given-names>AJ</given-names></name><name><surname>St&#x000fc;mper</surname><given-names>OF</given-names></name><name><surname>Hess</surname><given-names>J</given-names></name><etal/></person-group><article-title>Surgery for Ebstein's anomaly: the clinical and echocardiographic
evaluation of a new technique</article-title><source>J Am Coll Cardiol</source><year>1991</year><volume>17</volume><issue>3</issue><fpage>722</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(10)80190-1</pub-id><pub-id pub-id-type="pmid">1993793</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>SM</given-names></name><name><surname>Schreiber</surname><given-names>C</given-names></name><name><surname>Cheng</surname><given-names>W</given-names></name><name><surname>Lin</surname><given-names>K</given-names></name><name><surname>Sun</surname><given-names>JY</given-names></name><etal/></person-group><article-title>More than valve repair: effect of cone reconstruction on right
ventricular geometry and function in patients with Ebstein
anomaly</article-title><source>Int J Cardiol</source><year>2016</year><volume>206</volume><fpage>131</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2016.01.032</pub-id><pub-id pub-id-type="pmid">26788689</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>JP</given-names></name><name><surname>Silva Lda</surname><given-names>F</given-names></name><name><surname>Moreira</surname><given-names>LF</given-names></name><name><surname>Lopez</surname><given-names>LM</given-names></name><name><surname>Franchi</surname><given-names>SM</given-names></name><name><surname>Lianza</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Cone reconstruction in Ebstein's anomaly repair: early and
long-term results</article-title><source>Arq Bras Cardiol</source><year>2011</year><volume>97</volume><issue>3</issue><fpage>199</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1590/s0066-782x2011005000084</pub-id><pub-id pub-id-type="pmid">21830001</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>JP</given-names></name><name><surname>da Silva Lda</surname><given-names>F</given-names></name></person-group><article-title>Ebstein&#x02019;s anomaly of the tricuspid valve: the cone
repair</article-title><source>Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu</source><year>2012</year><volume>15</volume><issue>1</issue><fpage>38</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1053/j.pcsu.2012.01.008</pub-id><pub-id pub-id-type="pmid">22424507</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holst</surname><given-names>KA</given-names></name><name><surname>Dearani</surname><given-names>JA</given-names></name><name><surname>Said</surname><given-names>S</given-names></name><name><surname>Pike</surname><given-names>RB</given-names></name><name><surname>Connolly</surname><given-names>HM</given-names></name><name><surname>Cannon</surname><given-names>BC</given-names></name><etal/></person-group><article-title>Improving results of surgery for Ebstein anomaly: where are we
after 235 cone repairs?</article-title><source>Ann Thorac Surg</source><year>2018</year><volume>105</volume><issue>1</issue><fpage>160</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2017.09.058</pub-id><pub-id pub-id-type="pmid">29174783</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Qiu</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Hong</surname><given-names>H</given-names></name></person-group><article-title>Cone reconstruction of the tricuspid valve in Ebstein anomaly
with or without one and a half ventricle repair</article-title><source>J Thorac Cardiovasc Surg</source><year>2011</year><volume>141</volume><issue>5</issue><fpage>1178</fpage><lpage>1183</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2011.01.015</pub-id><pub-id pub-id-type="pmid">21320712</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>R</given-names></name><name><surname>Burri</surname><given-names>M</given-names></name><name><surname>Eschenbach</surname><given-names>LK</given-names></name><name><surname>Badiu</surname><given-names>CC</given-names></name><name><surname>da Silva</surname><given-names>JP</given-names></name><name><surname>Nagdyman</surname><given-names>N</given-names></name><etal/></person-group><article-title>Da Silva's cone repair for Ebstein's anomaly: effect on right
ventricular size and function</article-title><source>Eur J Cardiothorac Surg</source><year>2015</year><volume>48</volume><issue>2</issue><fpage>316</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1093/ejcts/ezu472</pub-id><pub-id pub-id-type="pmid">25535206</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beroukhim</surname><given-names>RS</given-names></name><name><surname>Jing</surname><given-names>L</given-names></name><name><surname>Harrild</surname><given-names>DM</given-names></name><name><surname>Fornwalt</surname><given-names>BK</given-names></name><name><surname>Mejia-Spiegeler</surname><given-names>A</given-names></name><name><surname>Rhodes</surname><given-names>J</given-names></name><etal/></person-group><article-title>Impact of the cone operation on left ventricular size, function,
and dyssynchrony in Ebstein anomaly: a cardiovascular magnetic resonance
study</article-title><source>J Cardiovasc Magn Reson</source><year>2018</year><volume>20</volume><issue>1</issue><fpage>32</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1186/s12968-018-0452-0</pub-id><pub-id pub-id-type="pmid">29783986</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goleski</surname><given-names>PJ</given-names></name><name><surname>Sheehan</surname><given-names>FH</given-names></name><name><surname>Chen</surname><given-names>SS</given-names></name><name><surname>Kilner</surname><given-names>PJ</given-names></name><name><surname>Gatzoulis</surname><given-names>MA</given-names></name></person-group><article-title>The shape and function of the left ventricle in Ebstein&#x02019;s
anomaly</article-title><source>Int J Cardiol</source><year>2014</year><volume>171</volume><issue>3</issue><fpage>404</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2013.12.037</pub-id><pub-id pub-id-type="pmid">24411210</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oxenius</surname><given-names>A</given-names></name><name><surname>Attenhofer Jost</surname><given-names>CH</given-names></name><name><surname>Pr&#x000ea;tre</surname><given-names>R</given-names></name><name><surname>Dave</surname><given-names>H</given-names></name><name><surname>Bauersfeld</surname><given-names>U</given-names></name><name><surname>Kretschmar</surname><given-names>O</given-names></name><etal/></person-group><article-title>Management and outcome of Ebstein's anomaly in
children</article-title><source>Cardiol Young</source><year>2013</year><volume>23</volume><issue>1</issue><fpage>27</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1017/S1047951112000224</pub-id><pub-id pub-id-type="pmid">22417890</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geerdink</surname><given-names>LM</given-names></name><name><surname>du Marchie Sarvaas</surname><given-names>GJ</given-names></name><name><surname>Kuipers</surname><given-names>IM</given-names></name><name><surname>Helbing</surname><given-names>WA</given-names></name><name><surname>Delhaas</surname><given-names>T</given-names></name><name><surname>Ter Heide</surname><given-names>H</given-names></name><etal/></person-group><article-title>Surgical outcome in pediatric patients with Ebstein&#x02019;s anomaly: a
multicenter, long-term study</article-title><source>Congenit Heart Dis</source><year>2017</year><volume>12</volume><issue>1</issue><fpage>32</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1111/chd.12404</pub-id><pub-id pub-id-type="pmid">27558473</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holst</surname><given-names>KA</given-names></name><name><surname>Dearani</surname><given-names>JA</given-names></name><name><surname>Said</surname><given-names>SM</given-names></name><name><surname>Davies</surname><given-names>RR</given-names></name><name><surname>Pizarro</surname><given-names>C</given-names></name><name><surname>Knott-Craig</surname><given-names>C</given-names></name><etal/></person-group><article-title>Surgical management and outcomes of Ebstein anomaly in neonates
and infants: a society of thoracic surgeons congenital heart surgery
database analysis</article-title><source>Ann Thorac Surg</source><year>2018</year><volume>106</volume><issue>3</issue><fpage>785</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2018.04.049</pub-id><pub-id pub-id-type="pmid">29777671</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luu</surname><given-names>Q</given-names></name><name><surname>Choudhary</surname><given-names>P</given-names></name><name><surname>Jackson</surname><given-names>D</given-names></name><name><surname>Canniffe</surname><given-names>C</given-names></name><name><surname>McGuire</surname><given-names>M</given-names></name><name><surname>Chard</surname><given-names>R</given-names></name><etal/></person-group><article-title>Ebstein's anomaly in those surviving to adult life - a single
centre experience</article-title><source>Heart Lung Circ</source><year>2015</year><volume>24</volume><issue>10</issue><fpage>996</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1016/j.hlc.2015.03.016</pub-id><pub-id pub-id-type="pmid">25911143</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attenhofer Jost</surname><given-names>CH</given-names></name><name><surname>Connolly</surname><given-names>HM</given-names></name><name><surname>Scott</surname><given-names>CG</given-names></name><name><surname>Burkhart</surname><given-names>HM</given-names></name><name><surname>Warnes</surname><given-names>CA</given-names></name><name><surname>Dearani</surname><given-names>JA</given-names></name></person-group><article-title>Outcome of cardiac surgery in patients 50 years of age or older
with Ebstein anomaly: survival and functional improvement</article-title><source>J Am Coll Cardiol</source><year>2012</year><volume>59</volume><issue>23</issue><fpage>2101</fpage><lpage>2106</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2012.03.020</pub-id><pub-id pub-id-type="pmid">22651867</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hetzer</surname><given-names>R</given-names></name><name><surname>Hacke</surname><given-names>P</given-names></name><name><surname>Javier</surname><given-names>M</given-names></name><name><surname>Miera</surname><given-names>O</given-names></name><name><surname>Schmitt</surname><given-names>K</given-names></name><name><surname>Weng</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The long-term impact of various techniques for tricuspid repair
in Ebstein&#x02019;s anomaly</article-title><source>J Thorac Cardiovasc Surg</source><year>2015</year><volume>150</volume><issue>5</issue><fpage>1212</fpage><lpage>1219</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2015.08.036</pub-id><pub-id pub-id-type="pmid">26349593</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>ML</given-names></name><name><surname>Dearani</surname><given-names>JA</given-names></name><name><surname>Danielson</surname><given-names>GK</given-names></name><name><surname>Cetta</surname><given-names>F</given-names></name><name><surname>Connolly</surname><given-names>HM</given-names></name><name><surname>Warnes</surname><given-names>CA</given-names></name><etal/></person-group><article-title>The outcomes of operations for 539 patients with Ebstein
anomaly</article-title><source>J Thorac Cardiovasc Surg</source><year>2008</year><volume>135</volume><issue>5</issue><fpage>1120</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2008.02.034</pub-id><pub-id pub-id-type="pmid">18455593</pub-id></element-citation></ref></ref-list></back></article>